WuXi Biologics is trading at HK$49.54, up +4.03%, with no confirmed company-specific catalyst identified for the November 9 move.
- The latest identified company announcements were dated November 3. The Fresenius biosimilars agreement was announced November 2; neither establishes a direct reason for this sessionβs gain.
- Supplied price history shows a sharp rally on November 4, followed by declines on November 5 and 6. No current-session volume information was provided.